Davin Rautiola is the CEO of Single Dose Therapeutics, where he leads the development of neuroadaptive treatments for psychiatric conditions. A University of Minnesota PhD graduate, he specializes in translational medicine and drug development strategy. People who have worked with him describe him as meticulous, hardworking, disciplined, and an excellent team player and leader.
In January 2026, he won a prize in a National Institute on Drug Abuse challenge for a proposal to treat amphetamine-type stimulant use disorder.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.